Whither immunotherapy?
Inflamed phenotype and immunotherapy: The H&N case
Date
08 Oct 2016Session
Whither immunotherapy?Presenters
Tanguy SeiwertAuthors
T. SeiwertAuthor affiliations
- Section Of Hematology/oncology, University of Chicago, 60637 - Chicago, IL/US
Resources
Login to access the resources on OncologyPRO.
If you do not have an ESMO account, please create one for free.
Resources from the same session
Introduction
Presenter: Ignacio Melero
Session: Whither immunotherapy?
Resources:
Slides
Webcast
Tumour landscape: Clues for new targets
Presenter: Jerome Galon
Session: Whither immunotherapy?
Resources:
Slides
Webcast
Converting a non-immunogenic into an immunogenic tumour
Presenter: Jason Luke
Session: Whither immunotherapy?
Resources:
Slides
Webcast
Combining immunotherapy: (ir)rational choices
Presenter: James Larkin
Session: Whither immunotherapy?
Resources:
Slides
Webcast
This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.
For more detailed information on the cookies we use, please check our Privacy Policy.
-
Necessary cookies enable core functionality. The website cannot function properly without these cookies, and can only be disabled by changing your browser preferences.